Home/Filings/4/0000914190-09-000243
4//SEC Filing

CARDIOVASCULAR SYSTEMS INC 4

Accession 0000914190-09-000243

CIK 0001222929operating

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 7:24 PM ET

Size

35.0 KB

Accession

0000914190-09-000243

Insider Transaction Report

Form 4
Period: 2009-02-25
Transactions
  • Conversion

    Common Stock

    2009-02-25+616,197616,197 total
  • Disposition from Tender

    Common Stock

    2009-02-25616,1970 total
  • Disposition from Tender

    Common Stock

    2009-02-25616,1970 total(indirect: Held by Easton Hunt Capital Partners, L.P.)
  • Conversion

    Common Stock

    2009-02-25+616,197616,197 total(indirect: Held by Easton Hunt Capital Partners, L.P.)
  • Conversion

    Series A Conv Preferred Stock

    2009-02-25616,1970 total
    Common Stock (616,197 underlying)
  • Conversion

    Warrant

    2009-02-25+87,49987,499 total
    From: 2006-07-19Exp: 2011-07-19Common Stock (87,499 underlying)
  • Conversion

    Warrant

    2009-02-2587,4990 total
    From: 2006-07-19Exp: 2011-07-19Series A Conv Preferred Stock (87,499 underlying)
  • Disposition from Tender

    Warrant

    2009-02-2587,4990 total
    Common Stock (87,499 underlying)
  • Disposition from Tender

    Warrant

    2009-02-25234,3390 total
    Common Stock (234,339 underlying)
  • Conversion

    Series A Conv Preferred Stock

    2009-02-25616,1970 total(indirect: Held by Easton Hunt Capital Partners, L.P.)
    Common Stock (616,197 underlying)
  • Conversion

    Warrant

    2009-02-2587,4990 total(indirect: Held by Easton Hunt Capital Partners, L.P.)
    From: 2006-07-19Exp: 2011-07-19Series A Conv Preferred Stock (87,499 underlying)
  • Conversion

    Warrant

    2009-02-25+87,49987,499 total(indirect: Held by Easton Hunt Capital Partners, L.P.)
    From: 2006-07-19Exp: 2011-07-19Common Stock (87,499 underlying)
  • Disposition from Tender

    Warrant

    2009-02-2587,4990 total(indirect: Held by Easton Hunt Capital Partners, L.P.)
    Common Stock (87,499 underlying)
  • Disposition from Tender

    Warrant

    2009-02-25166,6670 total(indirect: Held by Easton Hunt Capital Partners, L.P.)
    Common Stock (166,667 underlying)
  • Disposition from Tender

    Warrant

    2009-02-25234,3390 total(indirect: Held by Easton Hunt Capital Partners, L.P.)
    Common Stock (234,339 underlying)
Footnotes (5)
  • [F1]Immediately prior to the consummation of the merger between the issuer and Replidyne, Inc., each share of Series A convertible preferred stock was converted into approximately 1.005 shares of the issuer's common stock.
  • [F2]Disposed of pursuant to a merger agreement among the issuer, Responder Merger Sub, Inc. and Replidyne, Inc. (now known as "Cardiovascular Systems, Inc."), pursuant to which each share of the issuer's common stock was converted into 0.647 shares of common stock of Replidyne, Inc.
  • [F3]Immediately prior to the consummation of the merger between the issuer and Replidyne, Inc., each Series A convertible preferred stock warrant was converted into a warrant to purchase the issuer's common stock; each Series A convertible preferred share covered by the warrants was converted into approximately 1.005 shares of the issuer's common stock and the exercise price of each warrant was adjusted by multiplying the number of Series A shares covered by the warrant by the warrant exercise price, and dividing by the total number of the issuer's common shares subject to the converted Series A warrant.
  • [F4]Each share of Series A convertible preferred stock was convertible at any time, at the holder's election, into approximately 1.005 shares of common stock and had no expiration date.
  • [F5]Disposed of pursuant to a merger agreement among the issuer, Responder Merger Sub, Inc. and Replidyne, Inc. (now known as "Cardiovascular Systems, Inc."), pursuant to which each of the issuer's common stock warrants was assumed by Replidyne, Inc. and became exercisable to purchase shares of Replidyne, Inc. common stock; each share covered by the issuer's common stock warrants was converted into 0.647 shares of common stock of Replidyne, Inc., and the exercise price of each warrant was adjusted by dividing the pre-merger exercise price by 0.647 and rounding up to the nearest cent.

Issuer

CARDIOVASCULAR SYSTEMS INC

CIK 0001222929

Entity typeoperating
IncorporatedMN

Related Parties

1
  • filerCIK 0001222929

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 7:24 PM ET
Size
35.0 KB